Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma
2 ビュー
• 07/18/23
0
0
埋め込む
administrator
加入者
William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント